Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Neurocrine Biosciences Inc. (NBIX)

89.83   5 (5.89%) 03-21 16:00
Open: 86.5 Pre. Close: 84.83
High: 90.48 Low: 86.37
Volume: 1,372,853 Market Cap: 8158M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 90.582 - 90.942 90.942 - 91.252
Low: 85.4 - 85.833 85.833 - 86.206
Close: 89.064 - 89.788 89.788 - 90.411

Technical analysis

as of: 2019-03-21 4:29:55 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 105.68     One year: 123.43
Support: Support1: 80.73    Support2: 74.70
Resistance: Resistance1: 90.48    Resistance2: 105.68
Pivot: 81.57
Moving Average: MA(5): 86.30     MA(20): 81.07
MA(100): 85.93     MA(250): 95.63
MACD: MACD(12,26): 1.21     Signal(9): -0.02
Stochastic oscillator: %K(14,3): 91.02     %D(3): 91.00
RSI: RSI(14): 64.32
52-week: High: 126.98  Low: 64.72  Change(%): 7.2
Average Vol(K): 3-Month: 96046  10-Days: 81404

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
NBIX has closed below upper band by 0.4%. Bollinger Bands are 5.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 20 Mar 2019 19:06:33 Z
Sage Stock Pops on FDA Approval for Postpartum Depression Drug

Fri, 15 Mar 2019 15:16:48 Z
CTLT or NBIX: Which Is the Better Value Stock Right Now?

Thu, 14 Mar 2019 13:08:18 Z
Add Up The Pieces: AMCA Could Be Worth $31

Thu, 07 Mar 2019 16:08:11 Z
First Week of April 18th Options Trading For Neurocrine Biosciences (NBIX)

Thu, 07 Mar 2019 15:13:32 Z
Stocks Slide for Third Straight Day

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 90.82
Shares Float (M) 88.74
% Held by Insiders 2.30
% Held by Institutions 169.80
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS 0.170
EPS Est. Current Year -2.450
EPS Est. Next Year -1.700
EPS Est. Next Quarter -0.410
Forward EPS 1.830
Book Value (p.s.) 15.670
PEG Ratio -5.95
Profit Margin 4.68
Operating Margin 9.88
Return on Assets (ttm) 2.3
Return on Equity (ttm) 4.9
Qtrly Rev. Growth 39.1
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth 162.20
Operating Cash Flow (M) 101.36
Levered Free Cash Flow (M) 50.88

Stock Valuations

P/E 528.41
P/E Growth Ratio 0.06
P/BV 5.73
P/S 1631672192.00
P/CF 80.49

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date 1995-12-29
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.